Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02550431 · ClinicalTrials.gov registry record

Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth

A clinical trial of Transgendered Persons, sponsored by University of Colorado, Denver.

Completed
Registry status
58
Enrollment target
1
Study location

NCT02550431 is a study of Transgendered Persons that has completed, run by University of Colorado, Denver. The registered enrollment target is 58 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02550431, a study of Transgendered Persons, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
58 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about puberty blockers and cross (testosterone and estradiol). There is not much known about how these medications affect hormone levels, heart health and overall general health in young transgender individuals.

Conditions Studied

Study Locations (1)

Colorado

  • Children's Hospital Colorado - Aurora

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2016-03
Est. Completion 2018-01-26

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT02550431

The ClinicalTrials.gov registry entry for NCT02550431 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Transgendered Persons appearing as the primary indexed condition, and to 0 interventions.

NCT02550431 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT02550431 about?

NCT02550431 is a clinical study titled "Trans Health: Evaluation of Markers of Cardio-metabolic Health and Well-being in Transgender Youth". This study plans to learn more about puberty blockers and cross (testosterone and estradiol). There is not much known about how these medications affect hormone levels, heart health and overall general health in young transgender individuals.

What is the current status of trial NCT02550431?

This trial is currently completed. The enrollment target is 58 participants. The study started on 2016-03. Estimated completion is 2018-01-26.

What conditions does trial NCT02550431 study?

This clinical trial studies the following conditions: Transgendered Persons.

Who is sponsoring clinical trial NCT02550431?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02550431 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.